Welcome to our dedicated page for Genesis Heal SEC filings (Ticker: GENN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Genesis Heal's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Genesis Heal's regulatory disclosures and financial reporting.
Genneia S.A., a leading renewable power producer in Argentina, is pursuing an initial public offering of its Class B common shares, including shares represented by American Depositary Shares (ADSs), through a global offering split between an international tranche and a concurrent Argentine public offering. Only Class B shares are being sold; higher-vote Class A shares are not included.
The company operates 2,148 MW of gross installed capacity, of which 1,785 MW is wind and solar and 363 MW is thermal. For the three months ended March 31, 2026, revenues were U.S.$96.4 million, net income was U.S.$7.9 million, and Adjusted EBITDA with Joint Ventures was U.S.$73.1 million; for the LTM ended March 31, 2026, revenues were U.S.$376.8 million, net profit U.S.$97.2 million, and Adjusted EBITDA with Joint Ventures U.S.$286.5 million.
Genneia’s predominantly U.S. Dollar-denominated revenues are largely backed by long-term PPAs with CAMMESA and corporate customers under the MATER regime. The company has a substantial pipeline totaling 7,748 MW of potential portfolio (generation plus storage) and recently agreed to acquire an indirect 13.2% stake in Transener for approximately U.S.$178 million, subject to conditions. It qualifies as an emerging growth company and intends to use IPO proceeds to expand its Argentine operations and project pipeline.
Genneia S.A. and JPMorgan Chase Bank, N.A. are registering 250,000,000 American Depositary Shares (ADSs) evidenced by American Depositary Receipts, with each ADS representing one Class B common share of Genneia.
The registration uses a proposed maximum price of $0.05 per ADS, giving a proposed maximum aggregate offering price of $12,500,000 for SEC fee-calculation purposes and a registration fee of $1,726.25. Genneia is subject to U.S. Exchange Act reporting, and ADR holders can review its reports through the SEC’s EDGAR system.